PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript

PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript March 27, 2024 PDS Biotechnology Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. And welcome to PDS Biotech’s call to discuss the company’s Year-End 2023 Financial Results and […]

Related Keywords

Alabama ,United States ,Lars Boesgaard ,National Cancer ,National Cancer Institute ,Cancer Institute ,National Cancer Institute Led ,Katharine Price ,Mayo Clinic ,Hidden Gem Southern Cities ,Only Social ,Pds Biotech ,Tom Johnson ,Pds Biotechnology Corporation ,Clinical Programs ,R Kirk Shepard ,Financial Results ,Chief Medical Officer ,Cautionary Statements ,Head And Neck Cancer ,Dr Frank ,